Horizon Medicines LLC et al v. Aleor Dermaceuticals Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 20, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Vacant Judgeship (2022). Please include initials of VAC after the case number on all documents filed. (rjb) |
| Jul 20, 2022 | N/A | Order (0) Docket Text: ORAL ORDER: This case has been assigned to the District of Delaware's Vacant Judgeship ("VAC"). Detailed information relating to VAC cases may be found in the Court's Announcement of March 3, 2022 and Standing Order No. 2022-VAC-1 (March 9, 2022), which are found on the Court's website. Consistent with the foregoing Announcement and Standing Order, IT IS HEREBY ORDERED that the parties shall file the "Notice of Consent or Absence of Consent to Proceed Before a United States Magistrate Judge," being docketed along with the instant order, no later than sixty (60) days after service of the Complaint on the first defendant that is served. IT IS FURTHER ORDERED that the Notice, Consent, and Referral forms re: U.S. Magistrate Judge jurisdiction, previously docketed in this case, are VACATED. Issued by the Clerk of Court on 7/20/2022. (ntl) |
| Jul 20, 2022 | 6 | VAC Notice, Consent, Non-Consent, Magistrate Referral (1) Docket Text: VAC Notice, Consent, Non-Consent, Magistrate Referral (ntl) |
| Jul 18, 2022 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (mpb) |
| Jul 18, 2022 | 1 | Main Document (13) Docket Text: COMPLAINT filed against Aleor Dermaceuticals Ltd. ( Filing fee $ 402, receipt number ADEDC-3917385.) - filed by Horizon Medicines LLC, HZNP Medicines LLC, HZNP Finance LTD., Horizon Therapeutics Ireland DAC. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Civil Cover Sheet)(mpb) |
| Jul 18, 2022 | 1 | Exhibit A (32) |
| Jul 18, 2022 | 1 | Exhibit B (20) |
| Jul 18, 2022 | 1 | Civil Cover Sheet (1) |
| Jul 18, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
| Jul 18, 2022 | 3 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,066,913 B2. (mpb) |
| Jul 18, 2022 | 4 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/6/2022. Date of Expiration of Patent: 10/17/2027.Thirty Month Stay Deadline: 12/6/2024. (mpb) |
| Jul 18, 2022 | 1 | Complaint* (1) |
